Endogenous Recovery of Fasting C‐Peptide Decreases Progression of Sudomotor Small‐Fibre Dysfunction in Adults With Diabetes: A Real‐World Cohort Study
Diabetes/Metabolism Research and Reviews · 2026-05 · 42 (4)
DOI: 10.1002/dmrr.70173 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Diabetes/Metabolism Research and Reviews, online erschienen am 28.04.2026. Verfasst von Qingyun Cai und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Beijing Hospital, National Center of Gerontology, Beijing, China. Hauptthemen laut MEDLINE: C-Peptide, Diabetic Neuropathies, Fasting, Diabetes Mellitus, Type 2. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Noncommunicable Chronic Diseases-National Science and Technology Major Project of china.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Aims
To determine whether recovery of fasting C‐peptide (ΔFCP) reduces deterioration in sudomotor small‐fibre function, whether a threshold exists, and whether associations are complication‐specific.
Methods
Retrospective real‐world cohort of 288 hospitalised adults with diabetes with repeated fasting C‐peptide and Sudoscan electrochemical skin conductance (ESC). Deterioration in sudomotor small‐fibre function was defined as worsening foot ESC. Large‐fibre neuropathy (LFN) and diabetic kidney disease (DKD) progression were assessed by nerve conduction and kidney outcomes. Cox models, restricted cubic splines, maximally selected rank statistics, and subgroup/landmark/sensitivity analyses were performed.
Results
Over a median 2.2 years, higher ΔFCP was independently associated with lower risk of deterioration in sudomotor small‐fibre function, but not with LFN or DKD progression. Highest versus lowest ΔFCP tertile: adjusted HR 0.31 (95% CI 0.14–0.69; p < 0.001). An optimal ΔFCP cutoff of 126.8 pmol/L was identified; ΔFCP ≥ 126.8 pmol/L was associated with a 66% lower risk of sudomotor deterioration (HR 0.34, 95% CI 0.17–0.69; p < 0.001), remaining robust in landmark and sensitivity analyses. Baseline C‐peptide mediated little of the association.
Conclusions
Endogenous fasting C‐peptide recovery is linked to a clinically meaningful, threshold‐dependent reduction in the progression of sudomotor small‐fibre dysfunction, supporting β ‐cell preservation/recovery as targets in early diabetic neuropathy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology, Beijing Hospital, National Center of Gerontology, Beijing, China.
- Peking Union Medical College Graduate School, Chinese Academy of Medical Sciences, Beijing, China.
ORCID-Profile: Qingyun Cai, Lixin Guo, Qi Pan
Förderung
- Noncommunicable Chronic Diseases-National Science and Technology Major Project of china
Zitieren
APA
Cai, Q., Xie, T., Gong, H., Zhang, W., Guo, L., & Pan, Q. (2026). Endogenous Recovery of Fasting C‐Peptide Decreases Progression of Sudomotor Small‐Fibre Dysfunction in Adults With Diabetes: A Real‐World Cohort Study. Diabetes/Metabolism Research and Reviews, 42(4). https://doi.org/10.1002/dmrr.70173
Vancouver
Cai Q, Xie T, Gong H, Zhang W, Guo L, Pan Q. Endogenous Recovery of Fasting C‐Peptide Decreases Progression of Sudomotor Small‐Fibre Dysfunction in Adults With Diabetes: A Real‐World Cohort Study. Diabetes/Metabolism Research and Reviews. 2026;42(4). doi:10.1002/dmrr.70173
BibTeX
@article{Cai2026,
author = {Cai, Qingyun and Xie, Ting and Gong, Hongjian and Zhang, Wenjie and Guo, Lixin and Pan, Qi},
title = {Endogenous Recovery of Fasting C‐Peptide Decreases Progression of Sudomotor Small‐Fibre Dysfunction in Adults With Diabetes: A Real‐World Cohort Study},
journal = {Diabetes/Metabolism Research and Reviews},
year = {2026},
volume = {42},
number = {4},
doi = {10.1002/dmrr.70173}
}
EUVIMED